Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |